NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase Cosmos Health Inc COSM Q4 2025 Earnings EPS Misses Estimates by Wide Margin REVB Q1 2026 Earnings Significant EPS Miss Amid EarlyStage Development New Pacific Metals Corp NEWP Q1 2026 Earnings EPS Miss Marks Quarter of Operational Progress Amid Narrowing Losses QURE Q1 2026 Earnings NarrowerthanExpected Loss Amid Gene Therapy Pipeline Progress OMER Q1 2026 Earnings NarrowerThanExpected Loss Despite No Reported Revenue Shares Dip 42